BIOLASE(BIOL) - 2023 Q1 - Quarterly Report

Not applicable. ITEM 4. CONTROLS AND PROCEDURES Disclosure Controls and Procedures Our management has evaluated, with the participation of our President and Chief Executive Officer and our Chief Financial Officer, the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on that evaluation, our President and Chief Executive Officer and Chief Financial Officer have conclu ...